Will participate in a Fireside Chat at the H.C. Wainwright 4th Annual BioConnect Investor Conference ...
TORONTO , May 14, 2026 /PRNewswire/ -Â Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (" Cardiol " or the " Company "), a late-stage life sciences company advancing anti-inflammatory...
Today announced that the results from its Phase II study evaluating CardiolRxâ„¢ in patients with recurrent ...
TORONTO, ON , May 7, 2026 /PRNewswire/ -Â Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company advancing anti-inflammatory and anti-fibrotic...
TORONTO, ON , May 7, 2026 /CNW/ -Â Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company advancing anti-inflammatory and anti-fibrotic...
Today announced the continued expansion of its pivotal Phase III MAVERIC trial in the United States, ...
TORONTO , April 28, 2026 /PRNewswire/ - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (" Cardiol " or the " Company "), a late-stage life sciences company advancing anti-inflammatory...
TORONTO , April 28, 2026 /CNW/ - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (" Cardiol " or the " Company "), a late-stage life sciences company advancing anti-inflammatory and...
Toronto, Ontario--(Newsfile Corp. - April 20, 2026) - The following is a list of Upcoming Meeting Dates announced this week for Reporting Issuers in Canada. The data is supplied by Issuing Companies through...
Announced that Cardiol's President and Chief Executive Officer David Elsley, will participate in a live ...